Clinical Trial

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-03.
Trial Details
NCT Number NCT07521241
Lead Sponsor Addpharma Inc.
Conditions Chronic Liver Disease (CLD)
Enrollment 52 participants
Start Date 2026-05
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-13